Imugene Ltd
ASX:IMU
Imugene Ltd
Cash from Financing Activities
Imugene Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Imugene Ltd
ASX:IMU
|
Cash from Financing Activities
AU$83m
|
CAGR 3-Years
118%
|
CAGR 5-Years
35%
|
CAGR 10-Years
41%
|
|
Immutep Ltd
ASX:IMM
|
Cash from Financing Activities
AU$76m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
Mesoblast Ltd
ASX:MSB
|
Cash from Financing Activities
$67.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-8%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Cash from Financing Activities
-AU$2.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Cash from Financing Activities
AU$10.2m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Imugene Ltd's Cash from Financing Activities?
Cash from Financing Activities
83m
AUD
Based on the financial report for Dec 31, 2023, Imugene Ltd's Cash from Financing Activities amounts to 83m AUD.
What is Imugene Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
41%
Over the last year, the Cash from Financing Activities growth was -3%. The average annual Cash from Financing Activities growth rates for Imugene Ltd have been 118% over the past three years , 35% over the past five years , and 41% over the past ten years .